NasdaqGS - Delayed Quote • USD
Alphatec Holdings, Inc. (ATEC)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 4:03 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 7 | 7 | 7 | 6 |
Avg. Estimate | -0.31 | -0.29 | -1.09 | -0.76 |
Low Estimate | -0.38 | -0.34 | -1.34 | -1.32 |
High Estimate | -0.23 | -0.19 | -0.71 | -0.17 |
Year Ago EPS | -0.4 | -0.43 | -1.54 | -1.09 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 10 | 10 | 11 | 10 |
Avg. Estimate | 134.04M | 144.83M | 596.39M | 717.06M |
Low Estimate | 132.7M | 140.6M | 594.9M | 702M |
High Estimate | 136.6M | 147.6M | 604.6M | 753.3M |
Year Ago Sales | 109.11M | 116.92M | 482.26M | 596.39M |
Sales Growth (year/est) | 22.80% | 23.90% | 23.70% | 20.20% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -0.31 | -0.28 | -0.28 | -0.25 |
EPS Actual | -0.4 | -0.43 | -0.35 | -0.37 |
Difference | -0.09 | -0.15 | -0.07 | -0.12 |
Surprise % | -29.00% | -53.60% | -25.00% | -48.00% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.31 | -0.29 | -1.09 | -0.76 |
7 Days Ago | -0.31 | -0.29 | -1.09 | -0.76 |
30 Days Ago | -0.31 | -0.29 | -1.09 | -0.74 |
60 Days Ago | -0.24 | -0.23 | -0.96 | -0.59 |
90 Days Ago | -0.24 | -0.22 | -0.96 | -0.6 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | 2 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | ATEC | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 22.50% | -- | -- | 1.60% |
Next Qtr. | 32.60% | -- | -- | 10.50% |
Current Year | 29.20% | -- | -- | 5.20% |
Next Year | 30.30% | -- | -- | 13.30% |
Next 5 Years (per annum) | 12.00% | -- | -- | 11.22% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
Earnings
Upgrades & Downgrades
Maintains | Needham: Buy to Buy | 3/28/2024 |
Reiterates | Canaccord Genuity: Buy to Buy | 3/20/2024 |
Maintains | Needham: Buy to Buy | 3/20/2024 |
Reiterates | Needham: Buy to Buy | 3/13/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 3/4/2024 |
Reiterates | Needham: Buy to Buy | 2/28/2024 |
Related Tickers
GMED Globus Medical, Inc.
50.35
-0.79%
OFIX Orthofix Medical Inc.
13.10
+0.61%
FNA Paragon 28, Inc.
9.80
+1.55%
SIBN SI-BONE, Inc.
15.42
+0.78%
IART Integra LifeSciences Holdings Corporation
28.68
-9.33%
AXNX Axonics, Inc.
66.95
-0.15%
KIDS OrthoPediatrics Corp.
30.31
+2.89%
BVS Bioventus Inc.
4.4800
-1.54%
XTNT Xtant Medical Holdings, Inc.
0.8300
-0.86%
CNMD CONMED Corporation
72.64
+2.19%